KK
VIR icon

KLP Kapitalforvaltning’s Vir Biotechnology VIR Stock Holding History

KLP Kapitalforvaltning’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$315K Hold
30,900
– – ﹤0.01% 1709
2026
Q1 		$277K Buy
30,900
+11,500
+59% +$91.6K ﹤0.01% 1693
2025
Q4 		$117K Buy
19,400
+3,200
+20% +$19.1K ﹤0.01% 2029
2025
Q3 		$92.5K Hold
16,200
– – ﹤0.01% 2077
2025
Q2 		$81.6K Hold
16,200
– – ﹤0.01% 2091
2025
Q1 		$105K Hold
16,200
– – ﹤0.01% 2010
2024
Q4 		$119K Buy
+16,200
New +$128K ﹤0.01% 2022

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

KLP Kapitalforvaltning's VIR Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Vir Biotechnology (VIR) position steady in Q2 2026 at 30,900 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #1709.

KLP Kapitalforvaltning first reported a position in VIR in Q4 2024 and has held it in 7 quarters since. 238 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • KLP Kapitalforvaltning held 30,900 shares of Vir Biotechnology worth $315K as of Q2 2026.
  • KLP Kapitalforvaltning left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1709 holding.
  • KLP Kapitalforvaltning first reported a position in Vir Biotechnology in Q4 2024 and has held it in 7 quarters since.
  • 238 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.